Clinicians may now have a better tool for guiding therapy in men with prostate cancer who have had a prostatectomy and salvage radiation therapy (SRT). Investigators calculated genomic classifier (GC) scores for 166 patients based on genomic analysis of their own tumor tissue. They found this approach may enable clinicians to better personalize treatment options.
Study authors reported at the American Society for Radiation Oncology’s (ASTRO) 57th Annual Meeting, “Validation of a Genomic Classifier for Prediction of Metastasis Following Postoperative Salvage Radiation Therapy” on Wednesday, October 21, 2015, in San Antonio, that GC scores may be able to distinguish the patients for whom aggressive therapy is beneficial from those for whom SRT on its own is likely the best choice (scientific session, part of abstract 306).
– See more at: http://www.oncotherapynetwork.com/genitourinary-cancer-targets/genomic-classifier-may-help-predict-metastasis-following-prostatectomy-and-srt#sthash.oGVjs2Pz.dpuf